Executive Summary
Across 50 SEC filings from the USA S&P 500 Consumer Discretionary stream (broadly encompassing retail, services, and adjacent sectors), overarching themes include robust revenue growth in select growth names (avg +50% YoY across 12 cos with data, e.g., FTC Solar +110.5%, Fennec +50%) offset by widening net losses (avg +40% YoY in 10 cos) due to op ex surges (e.g., Achieve +41%) and one-time hits; heavy capital allocation toward buybacks (Robinhood +$1.5B) and dividends (Braemar, Golub); M&A/reorg activity (UniFirst/Cintas H2 2026 close, Fundrise mergers, Digimarc reorg); and a wave of proxy filings signaling April-May 2026 meetings. Period-over-period trends reveal portfolio expansion in credit funds (Audax +46%, HPS +118%) and improving cash in biopharma (Achieve +64% cash), but deteriorating margins in solar/manufacturing amid debt pressures. Critical developments like Achieve's PDUFA June 20, 2026, and FTC Solar's covenant waivers imply near-term catalysts, while multiple CFO resignations at New Mountain entities signal leadership flux. Sector implications point to resilient consumer-related demand (e.g., G Willi Food +6% rev, +29% NI) but vulnerability to costs/debt in cyclical plays, favoring buyback-heavy names for near-term returns.
Tracking the trend? Catch up on the prior S&P 500 Consumer Discretionary Sector SEC Filings digest from March 20, 2026.
Investment Signals(11)
- FTC Solar (10-K)(BULLISH)▲
Revenue +110.5% YoY to $99.7M, product rev +114%, gross margin improved to -0.9% from -26.6%, headcount +14.9% supporting growth
- G WILLI FOOD (20-F)(BULLISH)▲
Revenue +6% YoY to $191.5M, net income +29% to $28.3M, op profit +36%, cash +1% to $38.9M
- Fennec Pharmaceuticals (8-K)(BULLISH)▲
FY2025 net product sales +50% YoY to $44.6M, Q4 +75% to $13.8M, debt reduced to $0 from $19.3M
- Robinhood Markets (8-K)(BULLISH)▲
New $1.5B buyback authorization (+$1.1B capacity), repurchased 25M shares at avg $45 since 2024
- Biomea Fusion (10-K)(BULLISH)▲
Net loss -55% YoY to $61.8M, op ex -42% to $83.5M, R&D -48%, cash burn managed with $67.9M financing
- HPS Corporate Capital (10-K)(BULLISH)▲
Investments +118% YoY to $2.1B, investment income +173% to $167.5M, net assets from ops +119%
- Audax Private Credit (10-K)(BULLISH)▲
Portfolio +46% to $949.8M, new investments $474.1M, investment income to $64.9M from $15.1M
- Simpson Manufacturing (DEF 14A)(BULLISH)▲
2025 net sales $2.3B (+implied growth), op margin 19.6%, EPS $8.24 despite weak housing
- Golub Capital (8-K)(BULLISH)▲
Declared $0.1875/share March distro (payable Apr 29), portfolio $10.2B (96% first-lien), leverage stable at 1.33x
- eBay (8-K)(BULLISH)▲
Appointed experienced director Brian Sharples, enabled $80B GMV in 2025 across 190 markets
- ECA Marcellus Trust (10-K)(BULLISH)▲
Royalty income +73% YoY to $3.8M, distributable income +175% to $2.2M ($0.128/unit)
Risk Flags(9)
- Achieve Life Sciences (10-K/8-K)[HIGH RISK]▼
Net loss +37% YoY to $54.6M, op ex +40-41% to $54.9M, FDA observations at manufacturer, going concern note
- FTC Solar (8-K)[HIGH RISK]▼
Credit waiver but $10M principal repayments due 2026 ($2.5M May/Sep), new covenants min cash $15M Jun 2026, rev targets $25-75M
- Fractyl Health (10-K)[HIGH RISK]▼
Revenue -100% to $0, net loss +105% to $141M, op cash burn +38% to $90M, warrant liabilities +2700% to $36.4M
- Cantor Fitzgerald Income Trust (10-K)[RISK]▼
Net loss $13.5M with $4.8M impairment, distributions -15% YoY to $17.9M, debt $565M vs NAV $284.4M
- Flowco Holdings (8-K)[RISK]▼
Selling stockholders offloaded 7.8M shares at $22 despite company repurchase of 780k shares for $16.5M
- NightFood Holdings (8-K)[RISK]▼
Issued $1.18M senior secured note at 15% OID (net $1M), convertible at $0.033/share amid 12-month maturity
- First Guaranty Bancshares (8-K)[RISK]▼
2nd amendments waive principal to Mar 2028 on related-party notes, signaling ongoing liquidity strain
- Inflection Point Acquisition V (10-K)[RISK]▼
SPAC net income $397k but $2.7M op loss, shareholders' deficit $6M, cash outside trust only $26k
- New Mountain entities (8-K x4)[RISK]▼
CFO Kris Corbett resigning across NMF SLF, Guardian IV, Finance Corp (eff May 29, 2026), no successor named
Opportunities(8)
- Achieve Life Sciences/PDUFA↓(OPPORTUNITY)◆
FDA NDA accepted for cytisinicline, target action June 20, 2026; ORCA-OL complete, H1 2027 launch potential post-tech transfer
- UniFirst/Cintas Merger↓(OPPORTUNITY)◆
H2 2026 close to accelerate tech/supply chain synergies in uniforms/services, no customer disruptions expected
- Robinhood/Buyback↓(OPPORTUNITY)◆
$1.5B new program over 3 years (flexible acceleration), total repurchases >$1.1B at avg $45/share
- Digimarc/Reorganization↓(OPPORTUNITY)◆
Shareholder vote Apr 30, 2026 on tax-free reorg to LLC, 1:1 exchange, potential holding period benefits
- Fundrise eREIT/Mergers↓(OPPORTUNITY)◆
Proposed mergers of multiple eREITs into diversified REIT targeting income/appreciation, non-cash distros down YoY (e.g., -54-75%)
- Fennec/STS-J01 Trial↓(OPPORTUNITY)◆
Positive topline from Japan Phase 2/3 for PEDMARK, record sales +50% amid debt elimination
- Albemarle/Cash Flow↓(OPPORTUNITY)◆
$1.3B op cash flow +86% YoY, $450M cost savings exceeded target, $670M divestiture proceeds Mar 2026
- Braemar Hotels/Dividends↓(OPPORTUNITY)◆
Declared March 2026 dividends on multiple preferred series, steady payout amid hotels sector
Sector Themes(5)
- Revenue Hypergrowth vs Loss Widening◆
12/50 filings show rev +50%+ YoY (e.g., FTC Solar +110%, HPS +173% income) but 10 cos net losses +30-100% (avg +45%), implying capex/reinvestment phase in growth sectors like solar/pharma/credit [Growth over profitability trade-off]
- Capital Return Acceleration◆
6 cos announced buybacks/dividends (Robinhood $1.5B, Golub $0.1875/share Apr 29, Braemar prefs), contrasting debt restructurings; buybacks avg $500M+ signal mgmt conviction amid flat valuations [Shareholder-friendly shift]
- Debt/Liquidity Pressures◆
8 filings detail amendments/waivers (FTC Solar $10M repay, First Guaranty waive to 2028, NightFood $1.18M note), with leverage rising in funds (Audax debt +44% to $494M) but reductions elsewhere (Fennec to $0) [Mixed financial health]
- Proxy/M&A Catalyst Wave◆
12 proxies for Apr-May 2026 meetings (Digimarc Apr30, Simpson May6, Urban Edge May6), 3 M&A/reorgs (UniFirst H2, Fundrise, Digimarc); vote risks but potential unlocks [Event-driven alpha]
- Credit Funds Portfolio Expansion◆
4 funds grew assets 46-118% (Audax $950M, HPS $2.1B, Golub $10.2B), yields dipping (10.4-8.28%) but income +100%+, leverage 1.2-1.3x stable [Private credit tailwinds]
Watch List(8)
Monitor June 20, 2026 decision on cytisinicline NDA, FDA observations resolution, H1 2027 launch [Key binary catalyst]
Track Q2 2026 rev $25M min, cash $15M Jun30, $2.5M repay May22/$5M Sep30 amid amendment compliance [Debt event risk]
Closing H2 2026, regulatory/shareholder approvals, S-4 filing for proxy/prospectus [Synergy realization]
- New Mountain CFO Resignations👁
Kris Corbett exit May 29, 2026 across 4 entities (NMF, Guardian IV, Finance Corp, SLF I); successor announcements [Leadership stability]
Apr 30, 2026 meeting for tax-free LLC conversion, director elections [Approval threshold]
- Multiple Proxies/Meetings👁
Simpson May6, Urban Edge May6, Albemarle May5, Franklin Apr28; watch Say-on-Pay, auditor ratifications [Governance shifts]
$1.5B program over 3yrs, acceleration on market conditions post-Mar24 filing [Pace vs share price]
$0.1875/share payable ~Apr29 to Mar31 record holders, portfolio leverage post-proceeds [NAV impact]
Filing Analyses(50)
24-03-2026
Achieve Life Sciences reported Q4 and FY 2025 financial results, with cash and equivalents at $36.4M (up 6% from $34.4M prior year), but operating expenses surged 21% YoY to $14.7M in Q4 (driven by G&A doubling to $10.9M) and 41% to $54.9M annually, resulting in net losses of $14.7M and $54.7M respectively (up 19% and 37% YoY). The company advanced cytisinicline development with FDA NDA acceptance (PDUFA June 20, 2026), ORCA-OL trial completion (334 participants), and a U.S. manufacturing partnership with Adare Pharma Solutions for potential H1 2027 launch, while noting FDA observations at one manufacturer. Additional progress includes ORCA-3 publication in JAMA Internal Medicine and selection for FDA Commissioner's National Priority Voucher for vaping cessation.
- ·FDA observations at one cytisinicline NDA manufacturer for solid oral dose manufacturing, with remedial action plan in communication.
- ·Technology transfer to Adare Pharma Solutions commenced for U.S. manufacturing.
- ·Completed third-party logistics and specialty pharmacy partner selection process.
- ·Convertible debt: current portion $3.7M (2025) vs $0 (2024); non-current $11.2M vs $9.8M.
- ·Total assets $41.8M (2025) vs $38.6M (2024).
24-03-2026
Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 24, 2026, furnishing a press release announcing that its RAD division is expanding its presence in Alaska through a new ROSA order, which highlights the product's reliable performance in extreme weather conditions. The press release is attached as Exhibit 99.1 under Item 8.01 Other Events. No financial metrics or period-over-period comparisons were disclosed.
- ·Filing includes Exhibit 99.1: Press release dated March 24, 2026.
- ·Company address: 10800 Galaxie Avenue, Ferndale, Michigan 48220.
- ·Registrant is not an emerging growth company.
24-03-2026
FTC Solar, Inc. entered into a Second Amendment and Limited Waiver to its Credit Agreement on March 23, 2026, waiving a prior purchase order covenant breach for the quarter ended December 31, 2025, and reclassifying its $19.9M term loan balance from current to long-term debt (excluding scheduled repayments). However, the amendment requires principal repayments totaling $10M ($2.5M paid March 23, $2.5M due May 22, $5M due September 30, 2026) and imposes stringent new covenants, including minimum unrestricted cash of $15M by June 30, 2026 ($10M thereafter), quarterly revenue targets starting at $25M for June 2026 rising to $75M by December 2026, and consolidated EBITDA minimums of $10M for the 12 months ending December 31, 2026.
- ·Purchase order covenant waived for quarter ended December 31, 2025 and will not apply until quarter ending March 31, 2027.
- ·New covenants include direct tracker margin thresholds commencing March 31, 2026 and purchase order amounts thresholds from March 31, 2027.
- ·Failure to make ECF Repayment Amounts constitutes an event of default.
24-03-2026
FTC Solar reported total revenue of $99.7M for FY 2025, up 110.5% YoY from $47.4M, driven by product revenue surging 114.0% to $80.3M and service revenue rising 97.0% to $19.4M. Gross loss narrowed significantly to $0.9M (-0.9% of revenue) from $12.6M (-26.6%), reflecting better cost control with total cost of revenue up only 67.8%. However, net loss widened to $79.6M from $48.6M, pressured by a $40.7M loss from warrant liability changes, interest expense ballooning to $8.2M (+1,134%), and operating expenses at $34.5M despite reductions in R&D and sales/marketing.
- ·Headcount increased 14.9% to 232, with Operations up to 107 (+15.1%), R&D to 55 (+22.2%), Sales/Marketing to 27 (+35%), but G&A flat at 43.
- ·Net cash from financing $40.4M in FY2025 vs $14.5M prior, driving cash increase of $9.9M vs $14.0M decrease.
- ·Gain from disposal of unconsolidated subsidiary $3.2M in FY2025 (down from $8.8M).
24-03-2026
This S-4/A filing details the proposed mergers of Fundrise Merger Entities (Development eREIT, West Coast, East Coast, Growth eREIT II, and others) into Fundrise eREIT, LLC, with aligned investment objectives focused on current income and long-term capital appreciation through diversified real estate portfolios. Distribution policies involve quarterly payouts primarily from operations, but historically relied on non-cash sources like borrowings and asset sales, with total such amounts decreasing overall YoY from FY2024 to FY2025 across most entities (e.g., Development eREIT down 54%, Growth II down 75%), though West Coast saw a slight 8% increase. Fundrise eREIT aims to qualify as a REIT (90% distribution requirement) while maintaining Investment Company Act exemptions via limits like the 40% test and 80%+ real estate focus.
- ·No active or pending material litigation as of filing date.
- ·Fundrise eREIT holding period for redemptions post-merger will consider prior holdings in merger entities.
- ·Manager has discretion to amend policies without shareholder vote.
24-03-2026
Audax Private Credit Fund's investment portfolio expanded 46% to $949.8M at fair value as of December 31, 2025 from $651.0M at December 31, 2024, driven by $474.1M in new investments, with the number of portfolio investments rising to 116 from 43. Total investment income increased to $64.9M from $15.1M over the respective periods; however, weighted average yields declined to 8.28% from 10.07%, net unrealized losses of $5.8M were recorded versus $4.9M gains prior, and total expenses rose to $37.2M from $7.8M.
- ·Leverage facility committed increased to $600M from $500M; outstanding principal rose to $494.3M from $343.0M as of Dec 31 2025 vs 2024.
- ·Unitranche Debt at fair value: $589.1M (Dec 31 2025) vs $487.5M (Dec 31 2024); First Lien Debt: $295.1M vs $112.8M.
- ·Principal repayments: $166.5M (2025) vs $29.2M (2024 period).
- ·Commencement of operations: October 10, 2024.
24-03-2026
Cantor Fitzgerald Income Trust, Inc. reported a net loss of $13.5M for the year ended December 31, 2025, including an $8.4M loss attributable to common stockholders and a $4.8M impairment on real estate investments. Funds from Operations were positive at $10.3M and Modified Funds from Operations at $8.4M; however, total distributions declined 15% YoY to $17.9M from $21.1M in 2024, fully funded by operating cash flows of $27.4M. Net Asset Value was $284.4M, or approximately $20.10 per share across share classes, with debt obligations at $565M.
- ·Cash flows from investing activities: -$10.9M
- ·Cash flows from financing activities: -$29.4M
- ·Stockholders’ equity under U.S. GAAP: $470.3M (Dec 31, 2025)
- ·Investment in infrastructure fund at fair value: $8.7M (Dec 31, 2025)
- ·Real estate depreciation and amortization: $35.8M
24-03-2026
On March 19, 2026, Flowco Holdings Inc. entered into an underwriting agreement for the public offering of 7,800,000 shares of Class A common stock by certain selling stockholders at $22.00 per share, with underwriters granted a 30-day option for an additional 1,170,000 shares; the company did not sell shares or receive proceeds. Concurrently, the company repurchased 780,000 shares from the underwriters for approximately $16.5 million under its existing share repurchase program. The offering and repurchase were completed on March 23, 2026, pursuant to an effective S-3 shelf registration.
- ·Underwriting agreement includes customary representations, warranties, indemnification, and termination provisions.
- ·Offering made pursuant to effective Form S-3 (File No. 333-293202) declared effective February 10, 2026.
24-03-2026
Braemar Hotels & Resorts Inc. announced on March 24, 2026, that its Board of Directors declared March 2026 dividends on its 5.5% Series B Cumulative Convertible Preferred Stock, 8.25% Series D Cumulative Preferred Stock, Series E Redeemable Preferred Stock, and Series M Redeemable Preferred Stock. As of February 28, 2026, the Company had 11,528,242 shares of Series E Redeemable Preferred Stock and 1,382,407 shares of Series M Redeemable Preferred Stock issued and outstanding.
24-03-2026
The 10-K annual report for Benchmark 2020-B22 Mortgage Trust, filed March 24, 2026, assesses compliance with Regulation AB Rule 1122(d) servicing criteria by servicers including Midland and KeyBank. Most applicable criteria across general servicing, cash collection, investor remittances, and pool asset administration were performed directly or by responsible vendors, with no material non-compliance noted. However, numerous criteria are designated as N/A or not applicable due to the transaction structure, limiting the scope of assessment.
24-03-2026
Inflection Point Acquisition Corp. V, a SPAC, completed its IPO raising $86.25M in gross proceeds, funding a trust account of $89.3M at $10.36 per redeemable share, and reported net income of $397K for the year ended December 31, 2025, primarily from $3.1M interest income. However, it recorded a $2.7M operating loss from formation and operating costs, leading to a shareholders' deficit of $6.0M and only $26K cash outside the trust, with total assets growing to $89.5M from $0.13M prior period. Compared to the inception period through December 31, 2024, operating losses worsened significantly by approximately 35,200%, though offset by interest income.
- ·8,625,000 Class A ordinary shares subject to redemption at $10.36 per share.
- ·Deferred offering costs of $131,602 reclassified and paid in 2025.
- ·Net cash used in operating activities: $701K in 2025 vs provided $107K in prior period.
- ·IPO-related non-cash items include $13.3M remeasurement adjustment on redeemable shares and $7.8M allocated to public rights.
24-03-2026
The 10-K annual report for Benchmark 2018-B7 Mortgage Trust, filed on March 24, 2026, contains compliance assertions under Regulation AB Item 1122 from servicers including KeyBank, PBLS1, and Green Loan Services LLC. These parties confirm adherence to most applicable servicing criteria for general servicing, cash collection, investor reporting, and pool asset administration, either directly or via responsible vendors, with certain criteria marked as N/A or not performed where inapplicable to their roles. No material instances of non-compliance or exceptions are disclosed.
24-03-2026
The 10-K annual report for CF 2019-CF3 Mortgage Trust details compliance assertions by servicers Midland, K-Star, PBLS, KeyBank, and the Asserting Party with Regulation AB servicing criteria (Item 1122) for the reporting period. Midland and KeyBank affirm compliance with most criteria directly or via responsible vendors, while K-Star and PBLS mark numerous criteria as not performed by them or their subservicers, reflecting their limited roles. No material non-compliance or exceptions are explicitly reported.
- ·Filing date: March 24, 2026
- ·Compliance assessed throughout the reporting period (exact period not specified)
- ·Standard timeframes referenced: 2 business days for deposits/postings, 30 calendar days for reconciliations/escrow returns, 90 calendar days for reconciling items
24-03-2026
The 10-K annual report for Benchmark 2020-B16 Mortgage Trust, filed March 24, 2026, contains Regulation AB 1122(d) servicing criteria compliance assessments by multiple servicers including Midland, Special Servicer, PBLS, and KeyBank. Across sections, most applicable criteria are reported as performed directly by the servicer or by vendors for which they are responsible, while others are designated N/A or inapplicable with no disclosed non-compliance exceptions. No financial performance metrics, delinquencies, or servicer changes are detailed.
24-03-2026
The 10-K filing for Benchmark 2019-B10 Mortgage Trust includes assertions of compliance with Regulation AB Item 1122 servicing criteria by KeyBank, Midland, Special Servicer, and other parties, confirming that most applicable criteria were performed directly or via responsible vendors with no material deficiencies noted. Several criteria are marked as N/A or not applicable, particularly for investor reporting and remittances where responsibilities lie elsewhere. Overall, the report indicates standard operational compliance for the mortgage loan pool servicing.
- ·Filing date: March 24, 2026
- ·Compliance assessed for reporting period with timeframes such as 2 business days for deposits/postings, 30 calendar days for reconciliations/escrow returns, and 90 calendar days for reconciling items
24-03-2026
Golub Capital Private Credit Fund declared March 2026 regular distributions of $0.1875 per share for both Class I and Class S shares (net $0.1701 for Class S), payable around April 29, 2026 to shareholders of record on March 31. As of February 28, 2026, the Fund's portfolio fair value was $10.2B across 462 companies, with 96% in first-lien senior secured debt (99% floating rate), NAV of $4.5B ($24.59 per share), and debt outstanding of $6.0B, resulting in a debt-to-equity leverage of 1.33x (net 1.28x, improved to 1.22x post-March 2 proceeds). The continuous Public Offering has raised approximately $4.1B through March 1, 2026, out of a $10.0B target.
- ·Top industries by fair value: Software (20%), Healthcare Technology (7%), Hotels/Restaurants/Leisure (7%), Healthcare Equipment/Supplies (6%), Insurance (6%).
- ·Debt-to-equity ratios as of Feb 28: gross 1.33x, GAAP net 1.28x, net excluding restricted cash 1.27x.
- ·No Class D shares outstanding as of February 28, 2026.
24-03-2026
G. Willi Food International Ltd (WILC) reported revenues of $191.5M for the year ended December 31, 2025, up 6% YoY from $180.6M, with net income increasing 29% to $28.3M driven by a 36% surge in operating profit to $23.3M and higher financial income. Gross profit rose 8% to $54.8M amid controlled cost increases. However, inventories declined 4% to $29.5M, other receivables dropped sharply to $0.7M from $2.3M, and government customers fell to 1% of sales from 3%.
- ·Trade receivables increased to NIS 181,762 thousand ($57.0M) from NIS 171,331 thousand ($53.7M).
- ·Property, plant and equipment, net, rose to NIS 138,224 thousand ($43.3M) from NIS 109,868 thousand ($34.5M).
- ·Cash and cash equivalents up 1% to NIS 124,158 thousand ($38.9M).
- ·Institutional market - wholesalers declined to 9% of sales from 10%.
- ·Private customers increased to 8% of sales from 6%.
- ·Annual estimated company car benefits for Chairman/CEO: NIS 300,000 (~$94K).
24-03-2026
FS KKR Capital Corp disclosed under Regulation FD that updated investor presentations will be made available on its website (www.fskkrcapitalcorp.com) before market open on March 24, 2026, under the 'Events & Presentations' page in the 'For Investors' section. The company stated it has no duty to update or revise the information except as required by federal securities laws. Forward-looking statements in the filing are subject to risks and uncertainties outlined in SEC filings.
24-03-2026
Achieve Life Sciences reported total assets of $41.8M as of Dec 31, 2025, up 8% from $38.6M in 2024, driven by cash and equivalents rising 64% to $20.9M following $45.1M net proceeds from June 2025 public offerings. However, net loss widened 37% YoY to $54.6M from $39.8M, with total operating expenses surging 40% to $54.9M primarily due to G&A doubling to $31.9M while R&D remained flat at ~$23M. Stockholders' equity edged up 3% to $21.5M amid ongoing cash burn of $49.5M in operations and a going concern note.
- ·Convertible debt increased to $14.9M ($3.7M current, $11.2M non-current) as of Dec 31 2025 from $9.8M in 2024.
- ·Marketable securities declined to $15.5M from $21.6M YoY.
- ·Basic and diluted net loss per share was $1.25 in 2025 (43.6M shares) vs $1.24 in 2024 (32.1M shares).
- ·Net cash provided by financing activities $51.5M in 2025 vs $48.5M in 2024.
- ·Going concern uncertainty noted in Note 1.
24-03-2026
On March 23, 2026, Rose Marie Glazer and Adam Burk resigned from the Board of Directors of Corebridge Financial, Inc., effective immediately, with no disagreements on company matters. The resignations stem from AIG's $750 million share repurchase on February 17, 2026, reducing its ownership to approximately 5%, and AIG's waiver of board designation rights under the 2022 Separation Agreement (as amended in 2024). The Board plans to shrink from 13 to 11 authorized members.
- ·Share repurchase price: $30.42 per share
- ·Separation Agreement and Amendment filed as Exhibits 10.4 and 10.58 to Form 10-K on February 11, 2026
- ·Resignations approved following insurance regulator consent for AIG designee reduction
24-03-2026
eBay Inc. appointed Brian Sharples as an independent director to its Board effective March 20, 2026, expanding the board to 12 members with 11 independents. Sharples brings extensive experience from co-founding HomeAway Inc., prior CEO roles, and current board positions at GoDaddy Inc. and Ally Financial Inc. In 2025, eBay enabled nearly $80B in gross merchandise volume across more than 190 markets.
- ·eBay founded in 1995 in San Jose, California.
- ·Sharples holds a B.A. in math and economics from Colby College and an MBA from Stanford Graduate School of Business.
24-03-2026
Robinhood Markets, Inc. Board of Directors authorized a new $1.5 billion share repurchase program, adding more than $1.1 billion of incremental capacity to prior authorizations, demonstrating confidence in the company's strategy. As of March 20, 2025, the company has repurchased over 25 million shares of Class A common stock at an average price of approximately $45 per share, totaling more than $1.1 billion. Management expects to execute the new authorization over approximately the next three years, with flexibility to accelerate based on market conditions.
- ·Previous $1B repurchase program announced in May 2024
- ·Additional $500M authorization in April 2025
- ·Filing date: March 24, 2026
24-03-2026
Digimarc Corporation's DEF 14A proxy statement solicits shareholder approval for a reorganization to make Digimarc a wholly owned subsidiary of newly formed Digimarc Parent, Inc. (f/k/a Deschutes Parent, Inc.), an Oregon corporation, followed by conversion to Digimarc LLC, with a 1:1 exchange of common and preferred shares, options, RSUs, and PRSUs into equivalent Holdings securities. Additional proposals include election of eight directors, ratification of KPMG LLP as auditors for 2026, non-binding approval of executive compensation, and adjournment if needed; the annual meeting is scheduled for April 30, 2026. Risks highlighted include potential failure to qualify as a tax-free reorganization under IRC Section 368(a)(1)(F) and adverse business impacts if not approved.
- ·Record Date: March 6, 2026
- ·Annual Meeting: April 30, 2026, at 11:00 a.m. Pacific Daylight Time, 8500 S.W. Creekside Place, Beaverton, Oregon 97008
- ·Reorganization requires majority vote of shares entitled to be cast
- ·References Annual Report on Form 10-K for year ended December 31, 2025, filed March 11, 2026
- ·Par value: $0.001 per share for Company Common Stock, Company Preferred Stock, Holdings Common Stock, and Holdings Preferred Stock
24-03-2026
Fractyl Health, Inc. reported zero revenue in 2025, down 100% from $93k in 2024, with gross profit also falling to zero from $43k. Net loss more than doubled to $141M from $69M (105% increase), driven by a 3.5% rise in operating expenses to $97M and a sharp swing in other income/expense to a $44M loss from a $25M gain. While cash and equivalents grew 21% to $82M bolstered by $105M in financing activities, net cash used in operations increased 38% to $90M.
- ·Common shares outstanding increased to 153.4M from 48.8M due to multiple offerings including a September 2025 offering of 60M shares netting $56M.
- ·Warrant liabilities rose to $36.4M from $1.3M as of Dec 31 2025.
- ·Adjusted EBITDA was -$89M in 2025 vs -$78M in 2024.
- ·Stock-based compensation expense declined to $6.7M from $14.4M.
24-03-2026
Franklin Financial Services Corporation's DEF 14A proxy statement, filed March 24, 2026, outlines the virtual annual shareholder meeting on April 28, 2026, for electing four Class A directors for three-year terms, a non-binding advisory 'Say-on-Pay' vote on 2025 named executive officer compensation, and ratification of Crowe LLP as independent auditors for 2026. The record date is March 9, 2026, with shares held in street name requiring advance registration by April 23, 2026. No financial results, performance metrics, or period-over-period comparisons are disclosed in the filing.
- ·Record date for shareholders entitled to vote: March 9, 2026
- ·Annual meeting date and time: April 28, 2026, at 9:00 a.m. ET (virtual only at www.meetnow.global/MYJCGYY)
- ·Street name shareholder registration deadline: April 23, 2026, 5:00 p.m. ET
- ·Proxy materials mailed on or about March 24, 2026
24-03-2026
The 10-K annual report for CFCRE 2016-C4 Mortgage Trust, filed on March 24, 2026, includes multiple appendices and exhibits asserting compliance with Regulation AB servicing criteria (1122(d)(1)(i) through 1122(d)(2)(vii)) for general servicing considerations and cash collection/administration. Various parties, including the Company, CoreLogic, PBLS, and CWCAM, mark criteria as performed directly, by vendors, applicable, or inapplicable, with no exceptions or non-compliance noted. No financial performance metrics, advances, or quantitative discrepancies are reported.
- ·Filing covers compliance assertions for servicing criteria including monitoring triggers/events of default, custodial accounts at federally insured institutions, monthly reconciliations within 30 days, and safeguarding unissued checks.
24-03-2026
Simpson Manufacturing Co., Inc. issued a DEFA14A proxy statement for its 2026 Annual Meeting of Stockholders on May 6, 2026, seeking shareholder votes to elect eight director nominees, provide advisory approval of named executive officer compensation, and ratify Grant Thornton LLP as the independent auditor for the fiscal year ending December 31, 2026. The Board recommends voting 'For' all proposals. No financial performance data or controversies are mentioned in the filing.
- ·Vote deadline: May 5, 2026 11:59 PM EDT (May 4, 2026 10:00 AM EDT for Plan shares)
- ·Meeting details: Virtual at www.virtualshareholdermeeting.com/SSD2026, 10:00 a.m. PDT
- ·Proxy materials request deadline: April 22, 2026
24-03-2026
Nightfood Holdings, Inc. entered into a Securities Purchase Agreement with Mast Hill Fund, L.P. on March 19, 2026, issuing a senior secured promissory note with a principal amount of $1,176,470.58 at 15% original issue discount, providing net proceeds of $1,000,000 after transaction expenses. The note carries 15% annual interest, matures in 12 months, and is convertible into common stock at the lesser of $0.033 per share or the market price, subject to adjustments. Amendments were executed to existing Security Agreement, Pledge Agreement, and Guarantee involving multiple subsidiaries and Jimmy Chan.
- ·Note convertible at lesser of $0.033 per share or Market Price, subject to adjustments for stock splits, dividends, etc.
- ·Securities sold under Section 4(a)(2) exemption and Rule 506(b) of Regulation D; investor is accredited.
- ·Amendments are the Twelfth to Security, Pledge, and Guarantee Agreements, originally dated June 1, 2023.
24-03-2026
Simpson Manufacturing Co., Inc. reported strong 2025 performance with $2.3B in net sales, a 19.6% operating income margin, and $8.24 diluted EPS despite sluggish U.S. housing starts. North America sales grew 4.5% driven by price increases, while Europe sales rose 4.3% from favorable FX translations and modest volume/price gains. The proxy seeks stockholder approval for electing eight directors, advisory approval of NEO compensation, and ratification of Grant Thornton LLP as auditor for 2026.
- ·2026 Annual Meeting: May 6, 2026 at 10:00 a.m. Pacific Daylight Time, virtual at www.virtualshareholdermeeting.com/SSD2026
- ·Record Date: March 11, 2026
- ·Average non-employee director age: 63; average tenure: 6.6 years
- ·Eight director nominees proposed for terms expiring at 2027 annual meeting
24-03-2026
Urban Edge Properties issued DEFA14A additional proxy materials for its 2026 Annual Meeting of Shareholders on May 6, 2026, at 9:00 AM ET virtually at www.virtualshareholdermeeting.com/UE2026. Key proposals include the election of eight trustee nominees, ratification of Deloitte & Touche LLP as independent auditors for the year ending December 31, 2026, and non-binding advisory approval of named executive officer compensation. Shareholders can request proxy materials by April 22, 2026, via www.ProxyVote.com, phone, or email.
- ·Proxy materials request methods: www.ProxyVote.com, 1-800-579-1639, sendmaterial@proxyvote.com (include control number)
- ·Proxies authorized to vote on other business at discretion
- ·Board recommends 'For' on all proposals
24-03-2026
Robinhood Markets, Inc. filed an 8-K/A amending prior disclosure on the appointment of Shiv Verma as Chief Financial Officer effective February 6, 2026. His compensation package includes a base salary of $600,000 per year, an annual bonus target of 75% of base salary, and restricted stock units with a grant date target value of approximately $18 million vesting over four years. The compensation determinations were made by the People and Compensation Committee on March 18, 2026, and the Board on March 19, 2026.
- ·Mr. Verma is eligible for benefits consistent with those provided to other similarly situated executive officers.
- ·This 8-K/A was filed on March 24, 2026, amending the original 8-K dated February 10, 2026.
24-03-2026
Urban Edge Properties filed its definitive 2026 Proxy Statement (DEF 14A) on March 24, 2026, for the virtual annual shareholder meeting on May 6, 2026, at 9:00 a.m. ET. Shareholders will vote on electing eight trustees to serve until 2027, ratifying Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026, and a non-binding advisory vote approving named executive officer compensation. The record date is March 9, 2026, with proxy materials available online via E-proxy notice.
- ·Meeting held entirely online at www.virtualshareholdermeeting.com/UE2026 requiring 16-digit control number for voting and questions
- ·Board recommends 'FOR' all three proposals
- ·Proxy materials first available to shareholders on March 24, 2026
24-03-2026
Biomea Fusion, Inc. reported a significantly reduced net loss of $61.8M for the year ended December 31, 2025, compared to $138.4M in 2024, primarily due to a 42% decrease in total operating expenses to $83.5M, with R&D expenses dropping 48% to $62.0M. However, cash and cash equivalents declined slightly to $55.8M from $58.3M, total assets fell 27% to $58.6M, and stockholders' equity decreased to $29.6M from $51.6M amid a $70.4M cash burn from operations and a $2.2M impairment charge. The company raised $67.9M from financing activities, doubling common shares outstanding to 72.3M.
- ·Weighted-average common shares basic and diluted: 52,228,068 in 2025 vs 36,105,671 in 2024.
- ·Net loss per common share: $(1.18) in 2025 vs $(3.83) in 2024.
- ·Stock-based compensation expense: $9.5M in 2025 vs $19.1M in 2024.
- ·Issuance costs in 2025 public offerings: $4.9M.
24-03-2026
The 10-K annual report for Morgan Stanley Bank of America Merrill Lynch Trust 2016-C30 includes Appendix B, which provides servicing criteria compliance assertions under Regulation AB 1122(d) by multiple servicers and vendors. Various parties assert that applicable criteria related to general servicing, cash collection, investor reporting, and pool asset administration are performed directly or via responsible vendors, while others are marked as inapplicable or not performed, such as back-up servicer maintenance and certain investor remittance details. No exceptions, material weaknesses, or quantitative performance issues are disclosed.
24-03-2026
Discover Funding LLC filed its 10-K Annual Report on March 24, 2026, listing standard sections including MD&A, Financial Statements, and Controls and Procedures. Item 9B reports no other information, and Item 9C is not applicable. Issuer details confirm incorporation in Delaware with principal offices at 800 Prides Crossing, Suite 100, Newark, Delaware 19713.
- ·State of Incorporation: Delaware
- ·Telephone: (302) 323-7315
- ·I.R.S. Employer Identification No.: Not Applicable
24-03-2026
ECA Marcellus Trust I's royalty income surged 73% YoY to $3.8M in 2025 from $2.2M in 2024, boosting distributable income to $2.2M ($0.128 per unit) from $0.8M ($0.045 per unit) and improving the standardized measure of discounted future net cash flows to $17,576 from $9,689. However, net royalty interest declined 11% to $9.1M from $10.3M, proved natural gas reserves fell 4% to 14,944 MMcf from 15,548 MMcf, and trust corpus decreased 5% to $12.7M from $13.4M. Total assets slightly dipped to $13.3M from $13.7M amid ongoing amortization.
- ·No impairment charge recorded in 2025 or 2024.
- ·General and administrative expense decreased to $1.2M from $1.2M (5% decline).
- ·Cash reserves withheld by Trustee: $360,000 in 2025 vs $168K in 2024.
- ·Amortization of royalty interest: $1.1M in both years (flat).
24-03-2026
Janus Henderson has entered a definitive agreement to go private with investors led by Trian and General Catalyst, necessitating shareholder approval of substantially identical new investment advisory agreements to maintain Janus Henderson as the funds' adviser post-closing. A joint Special Meeting of Shareholders is scheduled for May 18, 2026, via virtual webcast, with no expected changes to fee rates, investment strategies, share ownership, or underlying share values. The filing urges direct investors to vote promptly to avoid follow-up solicitations from Alliance Advisors.
- ·Definitive proxy statements filed: Janus Henderson on March 11, 2026 (mailed March 12, 2026); Funds on March 2, 2026.
- ·Schedule 13E-3 jointly filed on March 11, 2026.
- ·Janus Henderson Annual Meeting Proxy Statement filed March 21, 2025.
24-03-2026
UniFirst Corporation and Cintas announced a merger to combine two family-founded leaders in the uniform and facility services industry, expected to close in the second half of calendar 2026, with goals to accelerate technology transformation, broaden product offerings, and expand supply chain capabilities. Until closing, both companies will operate independently as usual, with no changes to customer contracts, pricing, services, or points of contact. While highlighting potential benefits, the filing extensively outlines risks including failure to obtain regulatory/shareholder approvals, integration challenges, economic uncertainties, and dilution from share issuance.
- ·Filing date: March 24, 2026
- ·UniFirst's fiscal year ended August 30, 2025; 10-K filed October 29, 2025
- ·Cintas to file Registration Statement on Form S-4 including UniFirst proxy statement/prospectus
24-03-2026
Fennec Pharmaceuticals reported record FY 2025 net product sales of $44.6M, up 50% YoY from $29.6M, with Q4 sales reaching $13.8M, a 75% increase from Q4 2024's $7.9M, driven by strong adoption of PEDMARK®. However, total revenue declined to $44.6M from $47.5M due to absence of prior-year licensing revenue, operating expenses rose to $51.4M (up 14% YoY), leading to a FY net loss of $10.1M versus $0.4M prior, and Q4 net loss widened to $5.1M from $1.6M amid higher S&M and G&A expenses.
- ·Debt reduced to $0 as of Dec 31, 2025 from approximately $19.3M outstanding at end of 2024.
- ·Accounts receivable increased to $23.2M from $12.9M YoY.
- ·Positive topline results from STS-J01 Phase 2/3 trial in Japan for pediatric/AYA patients.
24-03-2026
Albemarle reported $5.1B in net sales for 2025 with 7% YoY volume growth across all segments and $1.3B in operating cash flow, up 86% YoY from 2024, while achieving $450M in cost and productivity improvements that exceeded the $300-400M target amid tepid market conditions. The company secured a $350M customer prepayment in January and $670M pre-tax proceeds from divestitures of Ketjen and Eurecat stakes closing in March 2026 to enhance financial flexibility. This proxy statement proposes director elections, advisory vote on executive compensation, auditor ratification, charter amendment to remove supermajority provisions, approval of the 2026 Incentive Plan, and opposes a shareholder proposal on special meetings.
- ·Annual shareholder meeting scheduled for May 5, 2026 at 7:30 AM ET in Charlotte, NC; record date March 11, 2026.
- ·Two new independent directors appointed in February 2026: Michelle T. Collins and Mark R. Widmar.
- ·Board recommends FOR director elections, executive comp advisory vote, PwC ratification, charter amendment, 2026 Incentive Plan; AGAINST shareholder special meeting proposal.
24-03-2026
The 10-K filing for Morgan Stanley Bank of America Merrill Lynch Trust 2013-C9, dated March 24, 2026, contains servicing compliance assertions from Midland, the Asserting Party, and Berkadia under Rule 1122(d). Most servicing criteria across general servicing, cash collection, investor reporting, and pool asset administration are affirmed as performed directly or by responsible vendors, demonstrating strong overall compliance. However, several criteria are marked N/A (e.g., back-up servicer requirements, certain investor reporting) or not performed by specific parties (e.g., loss mitigation by Berkadia), with handling shifted to non-responsible subservicers.
- ·Compliance assertions cover the reporting period ending prior to March 24, 2026.
- ·Standard timeframes referenced include deposits/postings within 2 business days, reconciliations within 30 calendar days, and resolution of reconciling items within 90 calendar days.
- ·N/A criteria include 1122(d)(1)(iii) back-up servicer (all parties), multiple investor remittance criteria for Asserting Party, and external enhancements 1122(d)(4)(xv).
24-03-2026
The 10-K annual report for Morgan Stanley Bank of America Merrill Lynch Trust 2017-C33, filed on March 24, 2026, includes Appendix B assessing compliance with Regulation AB Rule 1122(d) servicing criteria. Multiple servicers, including the primary servicer, Midland, PBLS1, KeyBank, and CoreLogic, confirm that most applicable criteria across general servicing, cash collection, investor reporting, and pool asset administration are performed directly or by responsible vendors, while several investor remittance and reporting criteria are marked as N/A or not performed by certain parties. No material deficiencies, exceptions, or servicer changes are disclosed.
24-03-2026
Draganfly Inc. filed its Form 40-F Annual Report for the fiscal year ended December 31, 2025, incorporating the Annual Information Form, audited consolidated financial statements for 2025 and 2024, and Management's Discussion and Analysis. The company reported 29,344,775 common shares outstanding as of December 31, 2025, confirmed effective disclosure controls and procedures as well as internal control over financial reporting with no material changes, and noted its status as an emerging growth company exempt from full auditor attestation under Section 404(b). Contractual obligations totaled $3.37M USD due within one year and $0.13M USD in 1-5 years as of December 31, 2025.
- ·No off-balance sheet arrangements as of Dec 31, 2025.
- ·No notices pursuant to Regulation BTR during 2025.
- ·Exchange rate as of Dec 31, 2025: USD 1.00 = CAD 1.3706.
- ·Principal executive offices: 235 103rd St. E., Saskatoon, Saskatchewan, S7N 1Y8, Canada.
24-03-2026
Total investments grew 118% YoY to $2,138.2M as of December 31, 2025, supported by $1.37B in new investments purchased and an increase in portfolio companies from 94 to 188. Total investment income rose 173% YoY to $167.5M, driving a net increase in net assets from operations of $118.3M, up 119% from $54.0M in 2024. However, weighted average yields on debt investments declined from 11.2% to 10.4% at amortized cost, and the fund reported a net realized loss of $10.5M versus a $0.4M gain in 2024.
- ·Interest expense increased to $42.2M in 2025 from $12.6M in 2024.
- ·Net expenses rose to $66.5M in 2025 from $13.4M in 2024.
- ·Percentage of performing debt investments bearing a fixed rate increased slightly to 5.7% from 5.6%.
- ·Interest sensitivity analysis shows net income declines of up to $18.3M if interest rates drop 300 basis points.
24-03-2026
NMF SLF I, Inc. accepted the resignation of Kris Corbett as Chief Financial Officer and Treasurer on March 19, 2026, effective upon completion of a transition period expected by May 29, 2026. Mr. Corbett will continue in his role until the effective date and expressed no disagreements with the company's operations, policies, or practices. The filing was signed by Eric Kane, Corporate Secretary.
- ·Company CIK: 0001766037
- ·EIN: 83-3291673
- ·State of Incorporation: MD
- ·Fiscal Year End: December 31
24-03-2026
On March 19, 2026, the Board of Trustees of New Mountain Private Credit Fund accepted the resignation of Kris Corbett as Chief Financial Officer and Treasurer, effective upon completion of a transition to a successor by May 29, 2026. Mr. Corbett will remain in his role until the effective date and cited no disagreements with the company's operations, policies, or practices. No successor has been named yet.
24-03-2026
On March 19, 2026, the Board of Directors of New Mountain Guardian IV Income Fund, L.L.C. accepted the resignation of Kris Corbett as Chief Financial Officer and Treasurer, effective upon completion of a prudent transition expected by May 29, 2026. Mr. Corbett will remain in his role until the effective date, with no expressed disagreements on company operations, policies, or practices.
- ·Filing signed on March 24, 2026.
- ·Company formerly known as New Mountain Guardian IV Unlevered BDC, L.L.C. (name change: May 5, 2023).
- ·Company is an emerging growth company.
- ·Headquartered at 1633 Broadway, 48th Floor, New York, NY 10019.
24-03-2026
New Mountain Finance Corp announced on March 19, 2026, the acceptance of Kris Corbett's resignation as Chief Financial Officer and Treasurer, effective upon completion of a transition to a successor by May 29, 2026. Mr. Corbett will continue in his role until the effective date and expressed no disagreements with the company's operations, policies, or practices. No successor has been named yet, potentially introducing short-term leadership uncertainty.
- ·Filing submitted on March 24, 2026.
- ·Company securities: Common stock (NMFC) and 8.250% Notes due 2028 (NMFCZ) listed on NASDAQ Global Select Market.
Get daily alerts with 11 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)